Trapping of human hemoglobin by haptoglobin: Molecular mechanisms and clinical applications

Antioxidants and Redox Signaling

Volumn 18, Issue 17, 2013, Pages 2364-2374

  Ratanasopa, Khuanpiroon ^a   Chakane, Sandeep ^a   Ilyas, Muhammad ^a   Nantasenamat, Chanin ^b   Bulow, Leif ^a  

^a LUND UNIVERSITY   (Sweden)

^b MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; HAPTOGLOBIN; HEME; HEMOGLOBIN;

GENE LOCUS; GLYCOSYLATION; HUMAN; MOLECULAR MECHANICS; OXIDATIVE STRESS; OXYGEN TRANSPORT; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; GLYCOSYLATION; HAPTOGLOBINS; HEME; HEMOGLOBINS; HUMANS; MODELS, MOLECULAR; MOLECULAR MIMICRY; PROTEIN BINDING; RECEPTORS, CELL SURFACE;

EID: 84876908109     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2012.4878     Document Type: Review

References (101)

1. Abd Hamid UM, Royle L, Saldova R, Radcliffe CM, Harvey DJ, Storr SJ, Pardo M, Antrobus R, Chapman CJ, Zitzmann N, Robertson JF, Dwek RA, and Rudd PM. A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology 18: 1105-1118, 2008. (Pubitemid 352762845)
2. Abdullah M, Marwitz S, Kahler D, Schultz H, Kugler C, Zabel P, Vollmer E, and Goldmann T. Pulmonary haptoglobin: a new marker for adenocarcinomas of the lung? Pathology 43: 70-72, 2011.
3. Akerstrom B. Tissue distribution of guinea pig a1-microglobulin. Cell Mol Biol 29: 489-495, 1983.
4. Alayash AI. Haptoglobin: old protein with new functions. Clin Chim Acta 412: 493-498, 2011.
5. Allhorn M, Berggard T, Nordberg J, Olsson ML, and Akerstrom B. Processing of the lipocalin a1-microglobulin by hemoglobin induces heme-binding and heme-degradation properties. Blood 99: 1894-1901, 2002. (Pubitemid 34525466)
6. Allhorn M, Klapyta A, and Akerstrom B. Redox properties of the lipocalin a1-microglobulin: reduction of cytochrome c, hemoglobin, and free iron. Free Radic Biol Med 38: 557-567, 2005. (Pubitemid 40416851)
7. Ang IL, Poon TCW, Lai PBS, Chan ATC, Ngai SM, Hui AY, Johnson PJ, and Sung JJY. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach. J Proteome Res 5: 2691-2700, 2006. (Pubitemid 44595171)
8. Ascenzi P, Bocedi A, Visca P, Altruda F, Tolosano E, Beringhelli T, and Fasano M. Hemoglobin and heme scavenging. IUBMB Life 57: 749-59, 2005. (Pubitemid 41781830)
9. Asleh R, Guetta J, Kalet-Litman S, Miller-Lotan R, and Levy AP. Haptoglobin genotype-And diabetes-dependent differences in iron-mediated oxidative stress in vitro and in vivo. Circ Res 96: 435-441, 2005. (Pubitemid 40354537)
10. Atkinson SH, Mwangi TW, Uyoga SM, Ogada E, Macharia AW, Marsh K, Prentice AM, and Williams TN. The haptoglobin 2-2 genotype is associated with a reduced incidence of plasmodium falciparum malaria in children on the Coast of Kenya. Clin Infect Dis 44: 802-809, 2007. (Pubitemid 46365304)
11. Azarov I, He X, Jeffers A, Basu S, Ucer B, Hantgan RR, Levy A, and Kim-Shapiro DB. Rate of nitric oxide scavenging by hemoglobin bound to haptoglobin. Nitric Oxide 18: 296-302, 2008.
12. Baker HM, Anderson BF, and Baker EN. Dealing with iron: common structural principles in proteins that transport iron and heme. Proc Natl Acad Sci USA 100: 3579-3583, 2003. (Pubitemid 36418076)
13. Belcher JD, Beckman JD, Balla G, Balla J, and Vercellotti G. Heme degradation and vascular injury. Antioxid Redox Signal 12: 233-248, 2010.
14. Boonyapranai K, Tsai H, Chen MCM, Sriyam S, Sinchaikul S, Phutrakul S, and Chen ST. Glycoproteomic analysis and molecular modeling of haptoglobin multimers. Electrophoresis 32: 1422-1432, 2011.
15. Boretti FS, Buehler PW, D'Agnillo F, Kluge K, Glaus T, Butt OI, Jia YP, Goede J, Pereira CP, Maggiorini M, Schoedon G, Alayash AI, and Schaer DJ. Sequestration of extracellular hemoglobin within a haptoglobin complex decreases its hypertensive and oxidative effects in dogs and guinea pigs. J Clin Invest 119: 2271-2280, 2009.
16. Borsody M, Burke A, Coplin W, Miller-Lotan R, and Levy A. Haptoglobin and the development of cerebral artery vasospasm after subarachnoid hemorrhage. Neurology 66: 634-640, 2006. (Pubitemid 43739814)
17. Budayova-Spano M, Lacroix M, Thielens NM, Arlaud GJ, Fontecilla-Camps JC, and Gaboriaud C. The crystal structure of the zymogen catalytic domain of complement protease C1r reveals that a disruptive mechanical stress is required to trigger activation of the C1 complex. EMBO J 21: 231-239, 2002. (Pubitemid 34137285)
18. Buehler PW, Abraham B, Vallelian F, Linnemayr C, Pereira CP, Cipollo JF, Jia YP, Mikolajczyk M, Boretti FS, Schoedon G, Alayash AI, and Schaer DJ. Haptoglobin preserves the CD163 hemoglobin scavenger pathway by shielding hemoglobin from peroxidative modification. Blood 113: 2578-2586, 2009.
19. Bunkenborg J, Pilch BJ, Podtelejnikov AV, and Wisniewski JR. Screening for N-glycosylated proteins by liquid chromatography mass spectrometry. Proteomics 4: 454-465, 2004. (Pubitemid 38235265)
20. Chatake T, Shibayama N, Park SY, Kurihara K, Tamada T, Tanaka I, Niimura N, Kuroki R, and Morimoto Y. Protonation states of buried histidine residues in human deoxyhemoglobin revealed by neutron crystallography. J Am Chem Soc 129: 14840-14851, 2007.
21. Chiao MT and Bezkorovainy A. Interaction of modified haptoglobin with hemoglobin. Biochim Biophys Acta 263: 60-69, 1972.
22. Cimen MY. Free radical metabolism in human erythrocytes. Clin Chim Acta 390: 1-11, 2008.
23. de Vries SJ, van Dijk M, and Bonvin AMJJ. The HADDOCK web server for data-driven biomolecular docking. Nat Protoc 5: 883-897, 2010.
24. Delanghe JR and Langlois MR. Hemopexin: a review of biological aspects and the role in laboratory medicine. Clin Chim Acta 312: 13-23, 2001. (Pubitemid 32913576)
25. Deterding LJ, Ramirez DC, Dubin JR, Mason RP, and Tomer KB. Identification of free radicals on hemoglobin from its self-peroxidation using mass spectrometry and immunospin trapping: observation of a histidinyl radical. J Biol Chem 279: 11600-11607, 2004. (Pubitemid 38401661)
26. Dolinsky TJ, Nielsen JE, McCammon JA, and Baker NA. PDB2PQR: an automated pipeline for the setup of Poisson-Boltzmann electrostatics calculations. Nucleic Acids Res 32: 665-667, 2004.
27. Dominguez C, Boelens R, and Bonvin AMJJ. HADDOCK: A protein-protein docking approach based on biochemical or biophysical information. J Am Chem Soc 125: 1731-1727, 2003.
28. Faye A, Ramey G, Foretz M, and Vaulont S. Haptoglobin is degraded by iron in C57BL/6 mice: A possible link with endoplasmic reticulum stress. Blood Cell Mol Dis 39: 229-237, 2007. (Pubitemid 47484464)
29. Fraczkiewicz R and Braun W. Exact and efficient analytical calculation of the accessible surface areas and their gradients for macromolecules. J Comp Chem 19: 319-333, 1998. (Pubitemid 128592649)
30. Ghesquière B, Van Damme J, Martens L, Vandekerckhove J, and Gevaert K. Proteome-wide characterization of Nglycosylation events by diagonal chromatography. J Proteome Res 5: 2438-2447, 2006. (Pubitemid 44330838)
31. Graversen JH, Madsen M, and Moestrup SK. CD163: a signal receptor scavenging haptoglobin-hemoglobin complexes from plasma. Int J Biochem Cell Biol 34: 309-314, 2002. (Pubitemid 34164272)
32. Grey M, Yainoy S, Prachayasittikul V, and Bulow L. A superoxide dismutase-human hemoglobin fusion protein showing enhanced antioxidative properties. FEBS J 276: 6195-6203, 2009.
33. Hvidberg V, Maniecki MB, Jacobsen C, Hojrup P, Moller HJ, and Moestrup SK. Identification of the receptor scavenging hemopexin-heme complexes. Blood 106: 2572 2579, 2005. (Pubitemid 41510836)
34. Hwang PK and Greer J. Identification of residues involved in the binding of hemoglobin alpha chains to haptoglobin. J Biol Chem 254: 2265-2270, 1979. (Pubitemid 9160041)
35. Jones S and Thornton JM. Protein-protein interactions: a review of protein dimer structures. Prog Biophys Mol Biol 63: 31-65, 1995.
36. Kapralov A, Vlasova II, Feng WH, Maeda A, Walson K, Tyurin VA, Huang ZT, Aneja RK, Carcillo J, Bayir H, and Kagan VE. Peroxidase activity of hemoglobin. Haptoglobin Complexes covalent aggregation and oxidative stress in plasma and macrophages. J Biol Chem 284: 30395-30407, 2009.
37. Kato GJ. Haptoglobin halts hemoglobin's havoc. J Clin Invest 119: 2140-2142, 2009.
38. Kazim AL and Atassi MZ. Haemoglobin binding with haptoglobin. Localization of the haptoglobin-binding site on the alpha-chain of human haemoglobin. Biochem J 197: 507-510, 1981. (Pubitemid 11013980)
39. Koda Y, Soejima M, Yoshioka N, and Kimura H. The haptoglobin-gene deletion responsible for anhaptoglobinemia. Am J Hum Genet 62: 245-252, 1998. (Pubitemid 28110765)
40. Kovalevsky AY, Chatake T, Shibayama N, Park SY, Ishikawa T, Mustyakimov M, Fisher Z, Langan P, and Morimoto Y. Direct determination of protonation states of histidine residues in a 2 A neutron structure of deoxyhuman normal adult hemoglobin and implications for the Bohr effect. J Mol Biol 398: 276-291, 2010.
41. Kristiansen M, Graversen JH, Jacobsen C, Sonne O, Hoffman HJ, Law SKA, and Moestrup SK. Identification of the haemoglobin scavenger receptor. Nature 409: 198-201, 2001. (Pubitemid 32144285)
42. Kurosky A, Barnett DR, Lee TH, Touchstone B, Hay RE Arnott MS, Bowman BH, and Fitch WM. Covalent structure of human haptoglobin-A serine protease homolog. Proc Natl Acad Sci USA 77: 3388-3392, 1980. (Pubitemid 10012242)
43. Lai IH, Lin KY, Larsson M, Yang MC, Shiau CH, Liao MH, and Mao SJT. A unique tetrameric structure of deer plasma haptoglobin-An evolutionary advantage in the Hp 2-2 phenotype with homogeneous structure. FEBS J 275: 981-993, 2008. (Pubitemid 351230215)
44. Langlois MR and Delanghe JR. Biological and clinical significance of haptoglobin polymorphism in humans. Clin Chem 42: 1589-1600, 1996. (Pubitemid 26354735)
45. Lardinois OM and Ortiz de Montellano PR. Autoreduction of ferryl myoglobin: discrimination among the three tyrosine and two tryptophan residues as electron donors. Biochemistry 43: 4601-4610, 2004. (Pubitemid 38500589)
46. Levy AP, Asleh R, Blum S, Levy NS, Miller-Lotan R, Kalet-Litman S, Anbinder Y, Lache O, Nakhoul FM, Asaf R, Farbstein D, Pollak M, Soloveichik YZ, Strauss M, Alshiek J, Livshits A, Schwartz A, Awad H, Jad K, and Hagit Goldenstein. Haptoglobin: basic and clinical aspects. Antioxid Redox Signal 12: 293-304, 2010.
47. Lim SK, Kim HK, Lim SK, bin Ali A, Lim YK, Chong SM, Costantini F, and Baumman H. Increased susceptibility in Hp knockout mice during acute hemolysis. Blood 92: 1870-1877, 1998. (Pubitemid 28446675)
48. Liu T, Qian WJ, Gritsenko MA, Camp DG, Monroe ME, Moore RJ, and Smith RD. Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J Proteome Res 4: 2070-2080, 2005. (Pubitemid 41814273)
49. Lustbader JW, Arcoleo JP, Birken S, and Greer J. Hemoglobin-binding site on haptoglobin probed by selective proteolysis. J Biol Chem 258: 1227-1234, 1983. (Pubitemid 13139367)
50. Maeda N, Yang F, Barnett DR, Bowman BH, and Smithies O. Duplication within the haptoglobin hp 2 gene. Nature 309: 131-135, 1984.
51. Malch B and Dixon GH. Studies on interchain disulfides of human haptoglobins. Can J Biochem 51: 249-264, 1973.
52. McEvoy SM and Maeda N. Complex events in the evolution of the haptoglobin gene cluster in primates. J Biol Chem 263: 15740-15747, 1988.
53. Melamed-Frank M, Lache O, Enav BI, Szafranek T, Levy NS, Ricklis RM, and Levy AP. Structure-function analysis of the antioxidant properties of haptoglobin. Blood 98: 3693-3698, 2001.
54. Miller YI, Altamentova SM, and Shaklai N. Oxidation of low-density lipoprotein by hemoglobin stems from a hemeinitiated globin radical: antioxidant role of haptoglobin. Biochemistry 36: 12189-12198, 1997. (Pubitemid 27440956)
55. Miyoshi E and Nakano M. Fucosylated haptoglobin is a novel marker for pancreatic cancer: Detailed analyses of oligosaccharide structures. Proteomics 8: 3257-3262, 2008.
56. Mosbach K. The promise of molecular imprinting. Sci Am 295: 86-91, 2006. (Pubitemid 44553956)
57. Nagel RL and Gibson QH. The binding of hemoglobin to haptoglobin and its relation to subunit dissociation of hemoglobin. J Biol Chem 246: 69-73, 1971.
58. Nagy E, Eaton JW, Jeney V, Soares MP, Varga Z, Galajda Z, Szentmikloski J, Mehes G, Csonka T, Smith A, Vercellotti GM, Balla G, and Balla, J Red cells, hemoglobin, heme, iron, and atherogenesis. Arterioscler Thromb Vasc Biol 30: 1347-1353, 2010.
59. Nakano M, Nakagawa T, Ito T, Kitada T, Hijioka T, Kasahara A, Tajiri M, Wada Y, Taniguchi N, and Miyoshi E. Site-specific analysis of N-glycans on haptoglobin in sera of patients with pancreatic cancer: a novel approach for the development of tumor markers. Int J Cancer 122: 2301-2309, 2008. (Pubitemid 351542335)
60. Nantesenamat, Virapong V, and Bulow L. Molecular modeling of the human hemoglobin-haptoglobin complex sheds light on the protective mechanisms of haptoglobin. Plos One 2012 (in press).
61. Nielsen MJ and Moestrup SK. Receptor targeting of hemoglobin mediated by the haptoglobins: roles beyond heme scavenging. Blood 114: 764-771, 2009.
62. Nielsen MJ, Moller HJ, and Moestrup SK. Hemoglobin and heme scavenger receptors. Antioxid Redox Signal 12: 261-273, 2010.
63. Nielsen MJ, Petersen SV, Jacobsen C, Thirup S, Enghild JJ, Graversen JH, and Moestrup SK. A unique loop extension in the serine protease domain of haptoglobin is essential for CD163 recognition of the haptoglobin-hemoglobin complex. J Biol Chem 282: 1072-1079, 2007. (Pubitemid 47076555)
64. Nooren IM and Thornton JM. Structural characterisation and functional significance of transient protein-protein interactions. J Mol Biol 325: 991-1018, 2003. (Pubitemid 36263408)
65. Okuyama N, Ide Y, Nakano M, Nakagawa T, Yamanaka K, Moriwaki K, Murata K, Ohigashi H, Yokoyama S, Eguchi H, Ishikawa O, Ito T, Kato M, Kasahara A, Kawano S, Gu JG, and Miyoshi E. Fucosylated haptoglobin is a novel marker for pancreatic cancer: A detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation. Int J Cancer 118: 2803-2808, 2006. (Pubitemid 43673360)
66. Olsson MG, Allhorn M, Bulow L, Hansson SR, Ley D, Olsson ML, Schmidtchen A, and Akerstrom B. Molecular mechanisms, clinical significance, and novel therapeutic opportunities for a1-microglobulin. Antioxid Redox Signal 17: 813-846, 2012.
67. Park SY, Lee SH, Kawasaki N, Itoh S, Kang K, Ryu SH, Hashii N, Kim JM, Kim JY, and Kim JH. a1-3/4 fucosylation at Asn 241 of b-haptoglobin is a novel marker for colon cancer: a combinatorial approach for development of glycan biomarkers. Int J Cancer30: 2366-2376, 2012.
68. Park SY, Yoon SJ, Hakomori SI, Kim JM, Kim JY, Bernert B, Ullman T, Itzkowitz SH, and Kim JH. Dimeric Le(a) (Le(a)-on-Le(a)) status of beta-haptoglobin in sera of colon cancer, chronic inflammatory disease and normal subjects. Int J Oncol 36: 1291-1297, 2010.
69. Park SY, Yoon SJ, Jeong YT, Kim JM, Kim JY, Bernert B, Ullman T, Itzkowitz SH, Kim JH, and Hakomoriet SI. Nglycosylation status of b-haptoglobin in sera of patients with colon cancer, chronic inflammatory diseases and normal subjects. Int J Cancer 126: 142-155, 2010.
70. Piacham T, Isarankura-Na-Ayudhya C, Prachayasittikul V, Bulow L, and Ye L. A polymer supported manganese catalyst useful as a superoxide dismutase mimic. Chem Commun 11: 1254-1255, 2003. (Pubitemid 36648976)
71. Pimenova T, Pereira CP, Gehrig P, Buehler PW, Schaer DJ, and Zenobi R. Quantitative mass spectrometry defines an oxidative hotspot in hemoglobin that is specifically protected by haptoglobin. J Proteome Res 9: 4061-4067, 2010.
72. Polonovski M and Jayle M. Existence in the blood plasma of a substance hastening the peroxydasic activity of the hemoglobin. Comp Rendus Séances Soc Biol Filial 129: 457-460, 1938.
73. Polticelli F, Bocedi A, Minervini G, and Ascenzi P. Human haptoglobin structure and function-A molecular modelling study. FEBS J 275: 5648-5656, 2008.
74. Poma A, Turner AP, and Piletsky SA. Advances in the manufacture of MIP nanoparticles. Trends Biotechnol 28: 629-637, 2010.
75. Reeder BJ. The redox activity of hemoglobins: from physiologic functions to pathologic mechanisms. Antioxid Redox Signal 13: 1087-1123, 2010.
76. Reeder BJ, Cutruzzola F, Bigotti MG, Hider RC, and Wilson MT. Tyrosine as a redox-Active center in electron transfer to ferryl heme in globins. Free Radic Biol Med 44: 274-283, 2008.
77. Reeder BJ, Grey M, Silaghi-Dumitrescu RL, Svistunenko DA, Bulow L, Cooper CE, and Wilson MT. Tyrosine residues as redox cofactors in human hemoglobin: implications for engineering non toxic blood substitutes. J Biol Chem 283: 30780-30787, 2008.
78. Roach JP, Moore EE, Partrick DA, Damle SS, Silliman CC, Mclntyre RC, and Banerjee A. Heme oxygenase-1 induction in macrophages by a hemoglobin-based oxygen carrier reduces endotoxin-stimulated cytokine secretion. Shock 31: 251-257, 2009.
79. Rother RP, Bell L, Hillmen P, and Gladwin MT. The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. JAMA 293: 1653-1662, 2005. (Pubitemid 40471796)
80. Saldova R, Wormald MR, Dwek RA, and Rudd PM. Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis. Dis Markers 25: 219-232, 2008.
81. Sammour RN, Nakhoul FM, Levy AP, Miller-Lotan R, Nakhoul N, Awad HR, Gonen R, and Ohel G. Haptoglobin phenotype in women with preeclampsia. Endocrine 38: 303-308, 2010.
82. Saridakis E, Khurshid S, Govada L, Phan Q, Hawkins D, Crichlow GV, Lolis E, Reddy SM, and Chayen NE. Protein crystallization facilitated by molecularly imprinted polymers. Proc Natl Acad Sci USA 108: 11081-11086, 2011.
83. Sarrats A, Saldova R, Pla E, Fort E, Harvey DJ, Struwe WB, de Llorens R, Rudd PM, and Peracaula R. Glycosylation of liver acute-phase proteins in pancreatic cancer and chronic pancreatitis. Proteomics-Clin Appl 4: 432-448, 2010.
84. Schaer DJ, Schaer CA, Buehler PW, Boykins RA, Schoedon G, Alayash AI, and Schaffner A. CD163 is the macrophage scavenger receptor for native and chemically modified hemoglobins in the absence of haptoglobin. Blood 107: 373-380, 2006. (Pubitemid 43053566)
85. Surugiu-Warnmark I, Warnmark A, Toresson G, Gustafsson JA, and Bulow L. Selection of DNA aptamers against rat liver X receptors. Biochem Biophys Res Commun 332: 512-517, 2005. (Pubitemid 40725006)
86. Tsai HY, Boonyapranai K, Sriyam S, Yu CJ, Wu SW, Khoo KH, Phutrakul S, and Chen ST. Glycoproteomics analysis to identify a glycoform on haptoglobin associated with lung cancer. Proteomics 11: 2162-2170, 2011.
87. Urushibara N, Kumazaki T, and Ishii S. Hemoglobinbinding site on human haptoglobin. Identification of lysyl residues participating in the binding. J Biol Chem 267: 13413-13417, 1992.
88. Vacic V, Oldfield CJ, Mohan A, Radivojac P, Cortese MS, Uversky VN, and Dunker AK. Characterization of molecular recognition features, MoRFs, and their binding partners. J Proteome Res 6: 2351-2366, 2007. (Pubitemid 46985123)
89. Vanhollebeke B, de Muylder G, Nielsen MJ, Pays A, Tebabi P, Dieu M, Raes M, Moestrup SK, and Pays E. A haptoglobin-hemoglobin receptor conveys innate immunity to Trypanosoma brucei in humans. Science 320: 677-681, 2008. (Pubitemid 351928352)
90. Vanhollebeke B and Pays E. The trypanolytic factor of human serum: many ways to enter the parasite, a single way to kill. Mol Microbiol 76: 806-814, 2010.
91. Wasserzug O, Blum S, Lejbkowicz F, Miller-Lotan R, and Levy AP. Haptoglobin 1-1 genotype and the risk of lifethreatening streptococcus infection: evolutionary implications. J Infect 54: 410, 2007. (Pubitemid 46430268)
92. Wejman JC, Hovsepian D, Walls JS, Hainfeld JF, and Greer J. Structure and assembly of haptoglobin polymers by electron microscopy. J Mol Biol 174: 343-368, 1984. (Pubitemid 15011744)
93. Wejman JC, Hovsepian D, Walls JS, Hainfeld JF, and Greer J. Structure of haptoglobin and the haptoglobinhemoglobin complex by electron microscopy. J Mol Biol 174: 319-341, 1984. (Pubitemid 15011743)
94. Wicher KB and Fries E. Haptoglobin, a hemoglobin-binding plasma protein, is present in bony fish and mammals but not in frog and chicken. Proc Natl Acad Sci USA 103: 4168-4173, 2006.
95. Wicher KB and Fries E. Convergent Evolution of Human and Bovine Haptoglobin: Partial Duplication of the Genes. J Mol Evol 65: 373-379, 2007. (Pubitemid 350050649)
96. Wicher KB and Fries E. Evolutionary aspects of hemoglobin scavengers. Antioxid Redox Signal 12: 249-259, 2010.
97. Wobeto VPD, Zaccariotto TR, and Sonati MDF. Polymorphism of human haptoglobin and its clinical importance. Genet Mol Biol 31: 602-620, 2008.
98. Yamamoto H. Efficacy of haptoglobin administration in the early postoperative course of patients with a diagnosis of HELLP syndrome. J Obstet Gynaecol 20: 610-611, 2000.
99. Yang F, Linehan LA, Friedrichs WE, Lalley PA, Sakaguchi AY, and Bowman BH. Characterization of the Mouse Haptoglobin Gene. Genomics 18: 374-380, 1993. (Pubitemid 23339549)
100. Yoon SJ, Park SY, Pang PC, Gallagher J, Gottesman JE, Dell A, Kim JH, and Hakomori SI. N-glycosylation status of beta-haptoglobin in sera of patients with prostate cancer vs. benign prostate diseases. Int J Oncol 36: 193-203, 2010.
101. Yoshioka N and Atassi MZ. Haemoglobin binding with haptoglobin. Localization of the haptoglobin-binding sites on the beta-chain of human haemoglobin by synthetic overlapping peptides encompassing the entire chain. Biochem J 234: 453-456, 1986. (Pubitemid 16049848)